A long-term prognostic significance of angiogenesis in breast carcinomas compare with Tie-2/Tek, CD105, and CD31 immunocytochemical expression showed both CD31 and CD105 correlated with poorer survival [19]. The gene discussed is PECAM1; the disease is breast carcinoma.